Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
Authors
Daisuke Takahari
Department of Gastrointestinal Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan;
Daisuke Takahari , Narikazu Boku , Satoru Iwasa , Junki Mizusawa , Tadayoshi Hashimoto , Takaki Yoshikawa , Shigenori Kadowaki , Nozomu Machida , Kenji Ishido , Masahiro Tsuda , Takahiro Kinoshita , Takushi Yasuda , Keisho Chin , Hiroaki Hata , Toshiyasu Ojima , Yasuhide Yamada , Masanori Terashima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 342)
DOI
10.1200/JCO.2023.41.4_suppl.342
Abstract #
342
Poster Bd #
E3
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Validation of the JCOG prognostic index in advanced gastric cancer of the SPIRITS and G-SOX trials, using individual patient data.
First Author: Daisuke Takahari
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic factors for PFS in patients with advanced gastric cancer: Using the data from JCOG9912 study.
First Author: Daisuke Takahari
Poster
2012 ASCO Annual Meeting
Tolerability and efficacy of a biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin regimen (TFOX) in previously advanced metastatic gastric and oesogastric junction (AGC) adenocarcinoma.
First Author: Simon Pernot
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.
First Author: Toshihiko Matsumoto